Home/Filings/4/0001104659-21-086944
4//SEC Filing

BioXcel LLC 4

Accession 0001104659-21-086944

CIK 0001720893other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 5:22 PM ET

Size

5.3 KB

Accession

0001104659-21-086944

Insider Transaction Report

Form 4
Period: 2021-06-25
BioXcel Corp
10% Owner
Transactions
  • Sale

    Common Stock

    2021-06-25$30.83/sh473,250$14,589,4938,546,750 total
Footnotes (1)
  • [F1]On June 25, 2021, the Reporting Person sold 473,250 shares of common stock of the Issuer as a selling stockholder in an underwritten public secondary offering at a price to the public of $31.70 per share . The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters after underwriting discounts and commissions.

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001651990

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:22 PM ET
Size
5.3 KB